KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Medpace Holdings (MEDP) Other Gross PP&E Adjustments (2016 - 2026)

Medpace Holdings filings provide 12 years of Other Gross PP&E Adjustments readings, the most recent being -$127.3 million for Q1 2026.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 2.52% to -$127.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$127.3 million, a 2.52% increase, with the full-year FY2025 number at $136.5 million, up 45.48% from a year prior.
  • Other Gross PP&E Adjustments hit -$127.3 million in Q1 2026 for Medpace Holdings, down from $136.5 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $136.5 million in Q4 2025 to a low of -$145.0 million in Q1 2023.
  • Median Other Gross PP&E Adjustments over the past 5 years was -$130.9 million (2024), compared with a mean of -$85.3 million.
  • The widest YoY moves for Other Gross PP&E Adjustments: up 123.85% in 2022, down 24.16% in 2022.
  • Medpace Holdings' Other Gross PP&E Adjustments stood at $32.9 million in 2022, then skyrocketed by 67.77% to $55.2 million in 2023, then skyrocketed by 70.02% to $93.8 million in 2024, then skyrocketed by 45.48% to $136.5 million in 2025, then crashed by 193.24% to -$127.3 million in 2026.
  • The last three reported values for Other Gross PP&E Adjustments were -$127.3 million (Q1 2026), $136.5 million (Q4 2025), and -$123.8 million (Q3 2025) per Business Quant data.